title: RE: Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.
authors.affiliation: Affiliations of authors: Catalytic Longevity, Carlsbad, CA (MFM); Mid America Heart Institute, St. Luke's Hospital, Kansas City, MO (JJD); Wegmans Pharmacy, Ithaca, NY (JJD); John Ochsner Heart and Vascular Institute, Ochsner Clinical School-University of Queensland School of Medicine, New Orleans, LA (CJL); Pennington Biomedical Research Center, Baton Rouge, LA (CJL); Mid America Heart Institute, University of Missouri, Kansas City, MO (JHO).
authors.forename: Mark F
authors.initials: MF
authors.lastname: McCarty
authors.forename: James J
authors.initials: JJ
authors.lastname: Dinicolantonio
authors.forename: Carl J
authors.initials: CJ
authors.lastname: Lavie
authors.forename: James H
authors.initials: JH
authors.lastname: O'Keefe
mesh_terms: D015525:Fatty Acids, Omega-3 / Q000009:adverse effects* / Q000097:blood*; D043371:Fatty Acids, Omega-6 / Q000097:blood*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000453:epidemiology*
chemical_list: D015525:Fatty Acids, Omega-3; D043371:Fatty Acids, Omega-6